|
inhibition of matrix metalloproteinases
|
inhibition_of_matrix_metalloproteinases |
|
|
F-box/WD repeat-containing protein 1A
|
PR_000004853 |
|
|
omeprazole pharmacodynamics pathway
|
PW_0000769 |
|
|
omeprazole drug pathway
|
PW_0000767 |
|
|
binding of IL-6 and IL-6 receptor
|
binding_of_IL-6_and_IL-6_receptor |
|
|
proton pump inhibitor drug pathway
|
PW_0000918 |
|
|
omeprazole pharmacokinetics pathway
|
PW_0000768 |
|
|
double-strand break repair
|
GO_0006302 |
|
|
double-strand break repair via nonhomologous end joining
|
GO_0006303 |
|
|
CXCR4-mediated signaling
|
CXCR4-mediated_signaling |
|
|
apoptotic DNA fragmentation
|
GO_0006309 |
|
|
GluR2-trafficking
|
GluR2-trafficking |
|
|
cGMP-specific 3',5'-cyclic phosphodiesterase
|
PR_000012477 |
|
|
ifosfamide pharmacokinetics pathway
|
PW_0000765 |
|
|
ifosfamide drug pathway
|
PW_0000764 |
|
|
RNA polymerase II transcription initiation and promoter clearance
|
RNA_polymerase_II_transcription_initiation_and_promoter_clearance |
|
|
celecoxib pharmacodynamics pathway
|
PW_0000763 |
|
|
celecoxib drug pathway
|
PW_0000761 |
|
|
Shc-binding RTK
|
Shc-Binding_RTK |
|
|
musculo-skeletal system drug pathway
|
PW_0001170 |
|
